Cargando…

A BIRC5(High) COD1(Low) Cancer Tissue Phenotype Indicates Poorer Prognosis of Metastatic Breast Cancer Patients

Extensive data research is helpful to find sensitive biomarkers for prognostic prediction of metastatic breast cancer. Through analyzing multiple GEO datasets, literature retrieval, and verified in GEPIA datasets, we identify BIRC5 (Baculoviral IAP repeat containing 5) and CDO1 (Cysteine dioxygenase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Yujie, Yuan, Feng, Yu, Jing, Si, Yibei, Zheng, Yiwen, Li, Dongqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208035/ https://www.ncbi.nlm.nih.gov/pubmed/35734521 http://dx.doi.org/10.1177/11769351221096655

Ejemplares similares

Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer
por: Hu, Tingting, et al.
Publicado: (2015)

BIRC3 and BIRC5: multi‐faceted inhibitors in cancer
por: Frazzi, Raffaele
Publicado: (2021)

Low serum albumin levels and high neutrophil counts are predictive of a poorer prognosis in patients with metastatic breast cancer
por: Xiang, Mengqi, et al.
Publicado: (2022)

BIRC5 promotes cancer progression and predicts prognosis in laryngeal squamous cell carcinoma
por: Wang, Nan, et al.
Publicado: (2022)

Bioinformatics analysis of BIRC5 in human cancers
por: Ye, Han-Bin, et al.
Publicado: (2022)

A lower psoas muscle index predicts a poorer prognosis in metastatic hormone‐naïve prostate cancer
por: Iwamoto, Genta, et al.
Publicado: (2020)

Baculoviral IAP Repeat Containing 6 (BIRC6) Is a Predictor of Prognosis in Prostate Cancer
por: Zhuang, Wenzhen, et al.
Publicado: (2018)

Socioeconomic variation in colon cancer tumour factors associated with poorer prognosis
por: Lyratzopoulos, G, et al.
Publicado: (2003)

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
por: Edwards, S M, et al.
Publicado: (2010)

BIRC2–BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia
por: Roohollahi, Khashayar, et al.
Publicado: (2022)

“New” metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapy
por: Twelves, Christopher, et al.
Publicado: (2015)

Poorer prognosis in young female patients with non-metastatic colorectal cancer: a hospital-based analysis of 5,047 patients in China
por: Shen, Lijun, et al.
Publicado: (2018)

Casein Kinase 1 Epsilon Expression Predicts Poorer Prognosis in Low T-Stage Oral Cancer Patients
por: Lin, Shu-Hui, et al.
Publicado: (2014)

High BIRC7 Expression Might Be an Independent Prognostic Indicator of Poor Recurrence-Free Survival in Patients With Prostate Cancer
por: Yang, Yi, et al.
Publicado: (2018)

Differential regulation of BIRC2 and BIRC3 expression by inflammatory cytokines and glucocorticoids in pulmonary epithelial cells
por: Thorne, Andrew, et al.
Publicado: (2023)

Publisher Correction: BIRC2–BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia
por: Roohollahi, Khashayar, et al.
Publicado: (2022)

The BIRC Family Genes Expression in Patients with Triple Negative Breast Cancer
por: Makuch-Kocka, Anna, et al.
Publicado: (2021)

Pan-cancer analysis identifies BIRC5 as a prognostic biomarker
por: Fäldt Beding, Anna, et al.
Publicado: (2022)

Regulation of Anti-Apoptotic SOD2 and BIRC3 in Periodontal Cells and Tissues
por: Rath-Deschner, Birgit, et al.
Publicado: (2021)

Lower treatment intensity and poorer survival in metastatic colorectal cancer patients who live alone
por: Cavalli-Björkman, N, et al.
Publicado: (2012)

Oncogenic activity of BIRC2 and BIRC3 mutants independent of nuclear factor-κB-activating potential
por: Yamato, Azusa, et al.
Publicado: (2015)

Plasma anti‐BIRC5 IgG may be a useful marker for evaluating the prognosis of nonsmall cell lung cancer
por: Zhao, Huan, et al.
Publicado: (2018)

Overexpression of SLC38A1 is associated with poorer prognosis in Chinese patients with gastric cancer
por: Xie, Jing, et al.
Publicado: (2014)

SAG expression associates with COPB2-related signaling and a poorer prognosis in breast cancer
por: Liu, Aiyu, et al.
Publicado: (2020)

Do ethnic chinese older adults with epithelial ovarian cancer survive a poorer prognosis?
por: Huang, Wu, et al.
Publicado: (2023)

Increased Expression of BIRC2, BIRC3, and BIRC5 from the IAP Family in Mesenchymal Stem Cells of the Umbilical Cord Wharton's Jelly (WJSC) in Younger Women Giving Birth Naturally
por: Gil-Kulik, Paulina, et al.
Publicado: (2020)

Malignant Melanoma in the Elderly: Different Regional Disease and Poorer Prognosis
por: Macdonald, James B., et al.
Publicado: (2011)

Initial misdiagnosis of melanoma located on the foot is associated with poorer prognosis
por: Sondermann, Wiebke, et al.
Publicado: (2016)

Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2021)

BIRC5 Genomic Copy Number Variation in Early-Onset Breast Cancer
por: Ghaffari, Kimia, et al.
Publicado: (2016)

Snail Promotes Cancer Cell Proliferation via Its Interaction with the BIRC3
por: Rho, Seung Bae, et al.
Publicado: (2022)

hnRNPA2B1 regulates the alternative splicing of BIRC5 to promote gastric cancer progression
por: Peng, Wei-zhao, et al.
Publicado: (2021)

Gene Network Revealed Involvements of Birc2, Birc3 and Tnfrsf1a in Anti-Apoptosis of Injured Peripheral Nerves
por: Wang, Yongjun, et al.
Publicado: (2012)

High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis
por: Wikberg, Maria L., et al.
Publicado: (2013)

Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer
por: Ma, Ben, et al.
Publicado: (2016)

Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City
por: Miyashita, H., et al.
Publicado: (2020)

Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients
por: He, Weiling, et al.
Publicado: (2013)

BIRC6 Protein, an Inhibitor of Apoptosis: Role in Survival of Human Prostate Cancer Cells
por: Low, Christopher G., et al.
Publicado: (2013)

Polymorphisms in Survivin (BIRC5 Gene) Are Associated with Age of Onset in Breast Cancer Patients
por: Sušac, Ilona, et al.
Publicado: (2019)

Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis
por: Dai, Jian-bo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aj90burieljblji9p7a293qau9